These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2386176)

  • 1. Flow cytometric quantitation of tumor-associated antigens in solid tumors.
    van Dam PA; Shepherd JH; Lowe DG; Watson JV
    Am J Obstet Gynecol; 1990 Aug; 163(2):698-9. PubMed ID: 2386176
    [No Abstract]   [Full Text] [Related]  

  • 2. Uterine tumors.
    Kato H
    Immunol Ser; 1990; 53():385-95. PubMed ID: 2100568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant tumors of the corpus uteri. Immunology and malignant tumors].
    Danesino V
    Minerva Ginecol; 1976 Mar; 28(3):208-11. PubMed ID: 62329
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunochemical study of 4 organ-specific human placental antigens in chorionepithelioma extracts].
    Petrunina IuA
    Akush Ginekol (Mosk); 1980 Apr; (4):14-5. PubMed ID: 7386748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary study on detecting the CA 125 value in endometrial washings].
    Chen DX; Schwartz PE
    Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):288-90, 312. PubMed ID: 3481694
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunology of nonteratogenic choriocarcinomas].
    Hausner P; Skrivan J; Jakoubková J; Zavadil M
    Cesk Gynekol; 1984 Jul; 49(6):436-9. PubMed ID: 6488339
    [No Abstract]   [Full Text] [Related]  

  • 10. [New antigens induced by herpes simplex virus in human tumors].
    Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical tissue localization of TA-4 and CEA in uterine carcinomas].
    Kimura A; Maruo T; Hoshina M; Mochizuki M
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1159-68. PubMed ID: 3323375
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical demonstration of HNK-1-defined antigen in endometrial carcinomas with argyrophil cells.
    Ueda G; Yamasaki M; Tanaka Y; Inoue Y; Nishino T; Saito J; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):1023-4. PubMed ID: 3894532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 14. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S; Black J; English DP; Schwab CL; Lopez S; Cocco E; Bonazzoli E; Predolini F; Ferrari F; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
    Am J Obstet Gynecol; 2016 Jan; 214(1):99.e1-8. PubMed ID: 26272866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Flow cytometric quantitation of the proliferation associated nuclear antigen p105 and DNA content of advanced gastric cancers as a prognostic factor: preliminary report].
    Kimura H; Yonemura Y; Ohyama S; Kamata T; Kosaka T; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):786. PubMed ID: 1975943
    [No Abstract]   [Full Text] [Related]  

  • 18. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in immunological studies of women with genital neoplasms].
    Paruch J
    Przegl Lek; 1982; 39(6):441-7. PubMed ID: 6753040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioimmunological determination of cancerocerebral antigen in the blood serum of patients with ovarian tumors].
    Griaznova IM; Borisenko SA; Sokolov AV; Prokopenko PG; Makarov OV
    Akush Ginekol (Mosk); 1984 Apr; (4):27-9. PubMed ID: 6204548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.